Estimates of the prevalence of speech and motor speech disorders in adolescents with Down syndrome.
Apraxia
assessment
classification
dysarthria
speech motor delay
Journal
Clinical linguistics & phonetics
ISSN: 1464-5076
Titre abrégé: Clin Linguist Phon
Pays: England
ID NLM: 8802622
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
22
6
2019
pubmed:
22
6
2019
medline:
4
9
2020
Statut:
ppublish
Résumé
Although there is substantial rationale for a motor component in the speech of persons with Down syndrome (DS), there presently are no published estimates of the prevalence of subtypes of motor speech disorders in DS. The goal of this research is to provide initial estimates of the prevalence of types of speech disorders and motor speech disorders in adolescents with DS. Conversational speech samples from a convenience sample of 45 adolescents with DS, ages 10 to 20 years old, were analysed using perceptual and acoustic methods and measures in the Speech Disorders Classification System (SDCS). The SDCS cross-classified participants into five mutually exclusive speech classifications and five mutually exclusive motor speech classifications. For participants meeting criteria for Childhood Dysarthria or for Childhood Dysarthria concurrent with Childhood Apraxia of Speech, the SDCS provided information on participants' percentile status on five subtypes of dysarthria. A total of 97.8% of participants met SDCS criteria for Speech Disorders and 97.8% met criteria for Motor Speech Disorders, including Childhood Dysarthria (37.8%), Speech Motor Delay (26.7%), Childhood Dysarthria and Childhood Apraxia of Speech (22.2%), and Childhood Apraxia of Speech (11.1%). Ataxia was the most prevalent dysarthria subtype. Nearly all participants with DS in the present sample had some type of speech and motor speech disorder, with implications for theory, assessment, prediction, and treatment. Specific to treatment, the present findings are interpreted as support for motor speech disorders as a primary explanatory construct to guide the selection and sequencing of treatment targets for persons with DS.
Identifiants
pubmed: 31221009
doi: 10.1080/02699206.2019.1595735
pmc: PMC6604065
mid: NIHMS1524507
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
772-789Subventions
Organisme : NIDCD NIH HHS
ID : R01 DC000496
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC013547
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD024356
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090256
Pays : United States
Références
BMC Med Res Methodol. 2002 Jun 17;2:8
pubmed: 12069695
J Speech Lang Hear Res. 2017 Jun 22;60(6S):1810-1817
pubmed: 28655050
J Speech Hear Res. 1993 Feb;36(1):105-40
pubmed: 8450654
Clin Linguist Phon. 2006 Jul;20(5):315-49
pubmed: 16728332
Front Hum Neurosci. 2016 Aug 30;10:440
pubmed: 27625603
J Speech Lang Hear Res. 2013 Feb;56(1):178-210
pubmed: 23275397
Curr Opin Behav Sci. 2016 Apr;8:282-288
pubmed: 27088121
Clin Linguist Phon. 2011 Apr;25(4):321-34
pubmed: 21091205
J Speech Lang Hear Res. 2013 Feb;56(1):123-36
pubmed: 22653916
Mol Psychiatry. 2019 Jul;24(7):1065-1078
pubmed: 29463886
J Autism Dev Disord. 2011 Apr;41(4):405-26
pubmed: 20972615
J Speech Lang Hear Res. 2017 Apr 14;60(4):S1096-S1117
pubmed: 28384779
Am J Ment Retard. 2007 Jul;112(4):289-99
pubmed: 17559295
J Speech Hear Res. 1994 Oct;37(5):1151-77
pubmed: 7823558
Int J Speech Lang Pathol. 2016 Oct;18(5):483-92
pubmed: 27063682
J Commun Disord. 2013 May-Jun;46(3):264-80
pubmed: 23628222
Clin Linguist Phon. 2010 Oct;24(10):795-824
pubmed: 20831378
J Speech Lang Hear Res. 2011 Apr;54(2):487-519
pubmed: 20966389
Clin Linguist Phon. 2019;33(8):790-814
pubmed: 31221010
Arch Clin Neuropsychol. 2016 Dec 1;31(8):1006-1025
pubmed: 27707700
Clin Linguist Phon. 2019;33(8):707-736
pubmed: 31221012
Prog Brain Res. 2012;197:101-21
pubmed: 22541290
Behav Genet. 2006 May;36(3):355-64
pubmed: 16505965
Downs Syndr Res Pract. 2006 Aug;11(1):9-17
pubmed: 17048805
Trends Neurosci. 2008 Jun;31(6):265-72
pubmed: 18471906
J Neurodev Disord. 2013 Oct 02;5(1):29
pubmed: 24083349
Am J Speech Lang Pathol. 2019 Feb 21;28(1):53-82
pubmed: 30515510
J Speech Hear Res. 1994 Oct;37(5):1100-26
pubmed: 7823556
Am J Psychiatry. 2001 Oct;158(10):1659-65
pubmed: 11578999
Semin Speech Lang. 2016 Nov;37(4):239-251
pubmed: 27701700
Am J Med Genet A. 2012 Jan;158A(1):174-81
pubmed: 22106036
Am J Ment Retard. 2008 May;113(3):214-30
pubmed: 18407723
BMJ. 1998 Apr 18;316(7139):1236-8
pubmed: 9553006
Brain Res. 2015 Feb 9;1597:47-56
pubmed: 25481413
Clin Linguist Phon. 2010 Oct;24(10):825-46
pubmed: 20831379
Brain Lang. 2016 Oct;161:1-3
pubmed: 27663062
Brain Lang. 2013 Dec;127(3):323-6
pubmed: 24189047
Clin Linguist Phon. 2019;33(8):679-706
pubmed: 30987467
Am J Speech Lang Pathol. 2017 Nov 08;26(4):1141-1158
pubmed: 28834534
J Speech Lang Hear Res. 2009 Oct;52(5):1189-212
pubmed: 19635944
Int J Speech Lang Pathol. 2018 Nov;20(6):581-582
pubmed: 31274356
Am J Ment Retard. 2003 May;108(3):149-60
pubmed: 12691594
Folia Phoniatr Logop. 2010;62(3):120-6
pubmed: 20424467
J Speech Lang Hear Res. 2000 Oct;43(5):1275-89
pubmed: 11063247
Eur J Hum Genet. 2013 Apr;21(4):455-9
pubmed: 22909774
J Speech Lang Hear Res. 1997 Aug;40(4):723-40
pubmed: 9263939
Int J Orofacial Myology. 1993 Nov;19:30-7
pubmed: 9601231
Am J Med Genet A. 2008 Sep 1;146A(17):2227-33
pubmed: 18671280
Am J Speech Lang Pathol. 2012 Aug;21(3):207-21
pubmed: 22442281
Genet Med. 2012 Nov;14(11):928-36
pubmed: 22766611
Cerebellum. 2007;6(1):58-65
pubmed: 17366266
Downs Syndr Res Pract. 2001 Oct;7(3):93-100
pubmed: 11721538
Hum Genet. 2016 Dec;135(12):1329-1341
pubmed: 27535846
Intern Med. 2010;49(9):861-4
pubmed: 20453409